Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Spironolactone plus finasteride reduces hirsutism more effectively.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Finasteride lowers cortisol and raises testosterone levels in rats.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.